Viktor Koelzer
Viktor Koelzer
Institute of Pathology and Molecular Pathology, University of Zurich
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ...
Nature medicine 24 (7), 994-1004, 2018
Tumor budding in colorectal cancer—ready for diagnostic practice?
VH Koelzer, I Zlobec, A Lugli
Human pathology 47 (1), 4-19, 2016
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ...
The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer
E Karamitopoulou, I Zlobec, V Kölzer, A Kondi-Pafiti, ES Patsouris, ...
Modern pathology 26 (2), 295-301, 2013
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer
M Horcic, VH Koelzer, E Karamitopoulou, L Terracciano, G Puppa, ...
Human pathology 44 (5), 697-705, 2013
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
VH Koelzer, SI Rothschild, D Zihler, A Wicki, B Willi, N Willi, M Voegeli, ...
Journal for immunotherapy of cancer 4 (1), 1-8, 2016
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study
VH Koelzer, I Zlobec, MD Berger, G Cathomas, H Dawson, K Dirschmid, ...
Virchows Archiv 466 (5), 485-493, 2015
CD103 is a hallmark of tumor‐infiltrating regulatory T cells
D Anz, W Mueller, M Golic, WG Kunz, M Rapp, VH Koelzer, J Ellermeier, ...
International journal of cancer 129 (10), 2417-2426, 2011
Immunostimulatory RNA blocks suppression by regulatory T cells
D Anz, VH Koelzer, S Moder, R Thaler, T Schwerd, K Lahl, T Sparwasser, ...
The journal of immunology 184 (2), 939-946, 2010
Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
I Zlobec, M Hädrich, H Dawson, VH Koelzer, M Borner, M Mallaev, ...
British journal of cancer 110 (4), 1008-1013, 2014
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
KD Mertz, LF Mager, MH Wasmer, T Thiesler, VH Koelzer, G Ruzzante, ...
Oncoimmunology 5 (1), e1062966, 2016
Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome
VH Koelzer, K Canonica, H Dawson, L Sokol, ...
Oncoimmunology 5 (4), e1106677, 2016
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
JA Galván, M Helbling, VH Koelzer, MP Tschan, MD Berger, M Hädrich, ...
Oncotarget 6 (2), 874, 2015
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
VH Koelzer, A Lugli, H Dawson, M Hädrich, MD Berger, M Borner, ...
Journal of translational medicine 12 (1), 81, 2014
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high‐level CpG Island methylator phenotype and mismatch repair‐deficiency
H Dawson, JA Galván, M Helbling, DE Muller, E Karamitopoulou, ...
International journal of cancer 134 (10), 2342-2351, 2014
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid …
I Zlobec, VH Koelzer, H Dawson, A Perren, A Lugli
Journal of translational medicine 11 (1), 1-7, 2013
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome
H Dawson, VH Koelzer, E Karamitopoulou, M Economou, C Hammer, ...
Histopathology 64 (4), 577-584, 2014
The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator
VH Koelzer, A Lugli
Frontiers in oncology 4, 29, 2014
Heterogeneity analysis of metastasis associated in colon cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
VH Koelzer, P Herrmann, I Zlobec, E Karamitopoulou, A Lugli, U Stein
BMC cancer 15 (1), 160, 2015
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
A Malesci, P Bianchi, G Celesti, G Basso, F Marchesi, F Grizzi, G Di Caro, ...
Oncoimmunology 6 (12), e1342918, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20